v3.26.1

Summary of Significant Accounting Policies (Tables) | 6 Months Ended | 12 Months Ended
--- | --- | ---
Nov. 30, 2025 | May 31, 2025
Summary of Significant Accounting Policies [Line Items] |  |
Schedule of Fair Value Hierarchy of the Group’s Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis |  | The following tables represent the fair value hierarchy of the Group’s financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2025 and there is no such financial liabilities measured at fair value on a recurring basis as of December 31, 2024.
|  | As of December 31, 2025
|  | Fair Value Measurement at the Reporting Date using
|  | Quoted price in active markets for identical assets Level 1 |  | Significant other observable inputs Level 2 |  | Significant unobservable inputs Level 3 |  | Total
Financial liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Warrant liabilities |  |  | — |  |  | — |  |  | 306,000 |  |  | 306,000
Total |  | $ | — |  | $ | — |  | $ | 306,000 |  | $ | 306,000
Schedule of Estimated Useful Lives |  | Depreciation of property and equipment is provided using the straight-line method over their estimated useful lives:
Computer equipment |  | 3 years
Furniture, fixture, and office and medical equipment |  | 5 years
Leasehold improvements |  | Shorter of the remaining lease terms or 5 years
Laboratory equipment |  | 5 years
Motor vehicle |  | 5 years
DiamiR Biosciences Corp. [Member] |  |
Summary of Significant Accounting Policies [Line Items] |  |
Schedule of Contract Assets and Deferred Revenues | Contract assets and deferred revenues related to contracts with customers consist of the following as of February 28, 2026 and May 31, 2025:
|  | Contract assets |  | Contract liabilities Deferred revenue
|  | Contract costs |  | Unbilled revenue |  | Total |
May 31, 2024 |  | $ | — |  | $ | — |  | $ | — |  | $ | —
Net change due to billings |  |  | — |  |  | — |  |  | — |  |  | 43,982
Revenue recognized |  |  | — |  |  | — |  |  | — |  |  | —
May 31, 2025 |  |  | — |  |  | — |  |  | — |  |  | 43,982
Net change due to billings |  |  | — |  |  | 86,373 |  |  | 86,373 |  |  | 10,000
Revenue recognized |  |  | — |  |  | 86,373 |  |  | 86,373 |  |  | 43,982
February 28, 2026 |  | $ | — |  | $ | — |  | $ | — |  | $ | 10,000
| Contract assets and deferred revenues related to contracts with customers consist of the following as of May 31, 2025 and May 31, 2024:
|  | Contract assets |  | Contract liability
Contract costs |  | Unbilled revenue |  | Total |  | Deferred revenue
May 31, 2023 |  | $ | — |  | $ | — |  | $ | — |  | $ | —
Net change due to billings |  |  | — |  |  | — |  |  | — |  |  | —
Revenue recognized |  |  | — |  |  | — |  |  | — |  |  | —
May 31, 2024 |  |  | — |  |  | — |  |  | — |  |  | —
Net change due to billings |  |  | — |  |  | — |  |  | — |  |  | 43,982
Revenue recognized |  |  | — |  |  | — |  |  | — |  |  | —
May 31, 2025 |  | $ | — |  | $ | — |  | $ | — |  | $ | 43,982

X
- Definition Tabular disclosure of estimated useful lives. + References No definition available. + Details
Name: | apm_PropertyPlantAndEquipmentUsefullLifeTableTextBlock
Namespace Prefix: | apm_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | apm_SummaryofSignificantAccountingPoliciesTablesLineItems
Namespace Prefix: | apm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=apm_DiamiRBiosciencesCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |